Posterior Narrow Diameter Implants in Hyperglycemic and Normo-glycemic Patients
NCT ID: NCT04630691
Last Updated: 2020-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2012-12-01
2017-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients with HbA1c around 6,0
Implantation
Patients received narrow diameter implants in posterior mandible or maxilla
T2DM
Patients with HbA1c above 6,5
Implantation
Patients received narrow diameter implants in posterior mandible or maxilla
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implantation
Patients received narrow diameter implants in posterior mandible or maxilla
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* periodontal surgery and/or antibiotic therapy within the last 6 months prior to baseline
* pregnancy and lactation period
* Full Mouth Plaque Score (FMPS) \> 25%
* untreated periodontitis
* smoking \> 10 cigarettes/day
* insufficient crestal volume making an augmentation procedure necessary
* previously performed ridge augmentation procedure for a staged implant placement
* permanent medication potentially affecting blood perfusion rate and bone metabolism
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Straumann AG
INDUSTRY
University of Witten/Herdecke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
References
Explore related publications, articles, or registry entries linked to this study.
Diehl D, Bespalov A, Yildiz MS, Friedmann A. Restoration of posterior teeth by narrow diameter implants in hyperglycemic and normoglycemic patients - 4-year results of a case-control study. Clin Oral Investig. 2024 Jun 22;28(7):392. doi: 10.1007/s00784-024-05786-0.
Diehl D, Kaner D, Bockholt A, Bilhan H, Friedmann A. Microcirculation and neutrophil-related cytokine concentrations are not altered around narrow diameter implants in T2DM patients during wound healing. Clin Oral Investig. 2023 Mar;27(3):1167-1175. doi: 10.1007/s00784-022-04731-3. Epub 2022 Oct 13.
Friedmann A, Winkler M, Diehl D, Yildiz MS, Bilhan H. One-year performance of posterior narrow diameter implants in hyperglycemic and normo-glycemic patients-a pilot study. Clin Oral Investig. 2021 Dec;25(12):6707-6715. doi: 10.1007/s00784-021-03957-x. Epub 2021 May 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UWHPerioT2DM
Identifier Type: -
Identifier Source: org_study_id